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Abstract
The aim of the present study was to compare the modulation of heart
rate in a group of postmenopausal women to that of a group of young
women under resting conditions on the basis of R-R interval variabil-
ity. Ten healthy postmenopausal women (mean – SD, 58.3 – 6.8 years)
and 10 healthy young women (mean – SD, 21.6 – 0.82 years) were
submitted to a control resting electrocardiogram (ECG) in the supine
and sitting positions over a period of 6 min. The ECG was obtained
from a one-channel heart monitor at the CM5 lead and processed and
stored using an analog to digital converter connected to a microcom-
puter. R-R intervals were calculated on a beat-to-beat basis from the
ECG recording in real time using a signal-processing software. Heart
rate variability (HRV) was expressed as standard deviation (RMSM)
and mean square root (RMSSD).  In the supine position, the postmeno-
pausal group showed significantly lower (P<0.05) median values of
RMSM (34.9) and RMSSD (22.32) than the young group (RMSM:
62.11 and RMSSD: 49.1). The same occurred in the sitting position
(RMSM: 33.0 and RMSSD: 18.9 compared to RMSM: 57.6 and
RMSSD: 42.8 for the young group). These results indicate a decrease
in parasympathetic modulation in postmenopausal women compared
to young women which was possibly due both to the influence of age
and hormonal factors. Thus, time domain HRV proved to be a nonin-
vasive and sensitive method for the identification of changes in
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Introduction
The heart is an organ under the influence
of the autonomic nervous system for the
maintenance of homeostasis, and, in this re-
spect, one of its main characteristics is the
constant modification of its rate on beat-to-
beat basis (1,2).
Also, it should be emphasized that heart
rate is a variable that can be measured in a
noninvasive manner with minimal error us-
ing simple and low-cost equipment. Today,
with the aid of digital computers, it has be-
come possible to study beat-to-beat heart
rate variability (HRV) obtained from the
R-R intervals in the electrocardiogram (ECG)
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recordings (3-5). This method has proved to
be of great clinical usefulness to evaluate the
balance of sympathetic and parasympathetic
regulation in several pathological conditions
(6-12). HRV has proved to be a more sensi-
tive tool for the detection of autonomic bal-
ance than mean heart rate (HR) (9).
The so-called measures in the time do-
main are indexes obtained from a continu-
ous ECG recording, which are used to deter-
mine the dispersion of the duration of the R
wave intervals among its mean or a reference
value. The various indexes proposed for the
measurement of HRV in the time domain
can be divided into three types: arithmetic,
geometric or statistical calculations (2,10,11).
A study of healthy volunteers using phar-
macological blockade with atropine docu-
mented a statistically significant reduction
in some HRV indexes in the time domain, a
fact that was not observed after blockade
with propranolol (13). These investigators
concluded that there is a correlation between
temporal variability indexes and vagal tonus
acting on the sinus node.
On the other hand, in patients with heart
disease, reduced HRV has been associated
with the occurrence of ventricular arrhyth-
mias, such as ventricular fibrillation and in-
creased mortality (9,10). The prevalence of
cardiovascular diseases increases with ad-
vancing age in women, especially after meno-
pause and among those with a sedentary life
style (14-16). Few studies have evaluated
neurocardiac parameters during the various
phases of womens life for the determination
of risk factors, a procedure that would be
useful and highly relevant for cardiovascular
evaluation of women at higher risk to de-
velop heart disease, thus permitting early
intervention.
Analysis of the HRV response can be
used to evaluate the adaptations of the auto-
nomic nervous system in women related to
changes due to aging and to the decreased
beneficial effects of natural estrogen on the
heart.
The objective of the present study was to
compare time domain HRV between post-
menopausal and young women under supine
and sitting resting conditions.
Methods
The study was conducted on 10 young
volunteers and 10 postmenopausal volun-
teers who were not on hormone replacement
therapy. Their anthropometric characteris-
tics, reported as mean and standard devia-
tions, were: age 21.6 – 0.82 years, weight
56.3 – 6.62 kg, and height 161.6 – 4.74 cm,
and age 58.3 – 6.8 years, weight 65.2 – 12.11
kg, and height 156.3 – 5.51 cm, respectively.
Both groups were composed of healthy non-
smoking women with a sedentary life style;
the volunteers were not taking any medica-
tions. Before the study the volunteers were
submitted to clinical and laboratory exami-
nations, including a resting ECG and dy-
namic exercise seated on a cycle ergometer
until they reached a target heart rate cor-
rected for age; this last test was used to
include in the study only women without
ischemic heart disease.
The study was approved by the Ethics
Committee of Universidade Federal de Sªo
Carlos and the volunteers gave written in-
formed consent to participate in the study.
The experiments were carried out in a
specially acclimatized room at 22oC and 60%
humidity, always at the same time of day in
order to avoid response differences due to
circadian changes. The volunteers were moni-
tored at the CM5 lead under resting condi-
tions in the supine and sitting positions. The
ECG and HR were obtained from a one-
channel heart monitor (ECAFIX TC500) and
processed using an analog-digital converter
Lab. PC+ (National Instruments, Co., Aus-
tin, TX, USA), which represents an interface
between the heart monitor and a Pentium II
microcomputer. Starting from the identifica-
tion of R peaks of the ECG waves, the R-
R intervals were calculated on a beat-to-beat
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basis from the ECG using a signal-process-
ing software (5). Systemic arterial pressure
was measured using a mercury column sphyg-
momanometer under resting conditions in
the supine and sitting positions. For the young
group, the recordings were always obtained
during the same period of the menstrual
cycle, i.e., between the 8th and the 10th
day of the cycle. R-R intervals were re-
corded over a period of 6 min under resting
conditions in the supine and sitting positions
and are shown in Figures 1 and 2, respec-
tively.
Two indexes were used for the measure-
ment of HRV, i.e., the standard deviations of
R-R intervals (RMSM or SDNN), and the
square root of the mean of the squared differ-
ences between adjacent normal R-R inter-
vals (RMSSD). RMSM corresponds to the
square root of the sum of squares of the
differences of individual values in relation
to the mean value divided by the number of
R-R intervals within a given time (Equation
1). RMSSD corresponds to the square root
of the mean sum of squares of the differ-
ences between the adjacent normal R-R in-
tervals in the record divided by the number
of R-R intervals within a given time minus





























where N = number of R-R intervals in the
series of selected data.
The Graphic Electrocardiogram Analyzer,
an application developed at the Laboratório
de Fisioterapia Cardiovascular, Universida-
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Figure 1. R-R interval, in ms, for the young (gray) and postmenopausal (black) volunteers
under resting conditions in the supine position (N = 2).
Figure 2. R-R interval, in ms, for the young (gray) and postmenopausal (black) volunteers
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Results
Table 1 shows the anthropometric char-
acteristics, body mass index, and clinical
and hormonal determinations for the studied
volunteers.
The results are presented in box plots as
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median, 1st and 3rd quartiles and outliers.
Data were analyzed statistically by the non-
parametric Mann-Whitney test for intergroup
comparison and by the Wilcoxon rank test
for intragroup analysis, with the level of
significance set at P<0.05. The analysis was
carried out using the Statistic for Windows
software, release 5.1. StatSoft, Inc., 1994-
1996.
Figures 3 and 4 illustrate the analysis of
HRV expressed as RMSM and RMSSD in-
dexes of R-R interval variability obtained for
the groups of postmenopausal and young
volunteers under resting conditions in the
supine and sitting positions. Intergroup anal-
ysis showed significant differences (P<0.05),
with lower RMSM and RMSSD indexes in
the menopausal group compared to the young
one. However, intragroup analysis showed
no significant differences (P>0.05) in HRV
indexes (RMSM and RMSSD) in the supine
or seated position. Figure 5 shows that there
was no significant difference (P>0.05) in
mean HR between the groups.
Discussion
Autonomic modulation is the main mech-
anism responsible for HR control in normal
volunteers. In this context, stimulation of the
parasympathetic nerves is associated with a
decrease in HR and an increase in its vari-
ability, whereas stimulation of the sympa-
thetic system is associated with an increase
in HR and a decrease in HR variability
(18,19). Under resting conditions, both the
sympathetic and parasympathetic systems
are tonically active, with a predominant va-
gal effect (1,2,11,18,19).
The literature has reported the use of a
great variety of different HRV indexes. How-
ever, it has not been definitely proved that
any one of these indexes is superior to an-
other (1,2,11,17).
The selection of the RMSM and RMSSD
in this study was based on the relatively high
sensitivity of these indexes due to the use of
Table 1. Anthropometric, clinical and hormonal characteristics of the groups studied.
Characteristic Young Postmenopausal
Age (years) 21.6 ± 0.82 58.3 ± 6.8**
Height (cm) 161.6 ± 4.74 156.3 ± 5.51*
Weight (kg) 56.3 ± 6.62 65.2 ± 12.11*
Body mass index (kg/m2) 21.4 ± 1.43 23.2 ± 6.42
Systolic blood pressure (mmHg) 108.2 ± 8.45 124.6 ± 14.6**
Diastolic blood pressure (mmHg) 71.4 ± 7.44 78.5 ± 9.07*
Follicle-stimulating hormone level (mIU/ml) 4.8 ± 0.78 79.1 ± 35.54**
Luteinizing hormone level (mIU/ml) 3.1 ± 0.76 22.1 ± 10.66**
Prolactin level (ng/ml) 11.6 ± 5.48 4.5 ± 1.71**
Serum estradiol level (pg/ml) 43.7 ± 8.23 <20a*
Values are reported as means ± SD. aLower concentration of assay standard curve. N =
10 for each group. *P<0.05 and **P<0.001 compared to young volunteers (Mann-
Whitney test).
Figure 3. RMSM indexes, the
standard deviation of R-R inter-
vals, in ms, for the young group
(N = 10) and the postmeno-
pausal group (N = 10) under rest-


































































Figure 4. RMSSD indexes, the
square root of the mean of the
squared differences between
adjacent normal R-R intervals, in
ms, for the young group (N = 10)
and the postmenopausal group
(N = 10) under resting conditions
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squares of the differences (17). The choice
of a 6-min recording period for assessment
of HRV, i.e., the so-called short-term assess-
ment, was based on the fact that this time
interval is sufficient to allow a full stabiliza-
tion of R-R interval variability, as reported
in most studies in this area (2,20,21). Fi-
nally, compared to frequency domain in-
dexes, time domain indexes are less restric-
tive in terms of the occurrence of nonlinearity,
particularly when different age groups are
compared (2,11).
Several studies have shown that HRV
declines with age in both sexes. The rela-
tively greater high frequency component of
total variability reported in women in the age
range of 35 to 65 years may be responsible
for the overall protection of women com-
pared to men against coronary heart disease,
and in particular coronary mortality and sud-
den cardiac death in this age range. Also, the
present study confirms the loss of heart pro-
tection in postmenopausal women. A pos-
sible protective mechanism in younger
women could be the reduction of arrhyth-
mias related to enhanced vagal activity
(14,21).
However, different results related to the
aging and gender effects of HRV have been
reported in other studies. Some investigators
(22), using a methodology similar to ours for
the evaluation of young men and middle-
aged men with active life styles, found no
significant differences in HRV indexes
(RMSM and RMSSD) related to body posi-
tion, indicating that the vagal-sympathetic
modulation was unchanged under these con-
ditions. In another recent study (14), the
authors observed that HRV (time and fre-
quency domain measures) declined with ad-
vancing age in healthy sedentary and physi-
cally active women, suggesting that a reduc-
tion in HRV with age may be an inevitable
consequence of the aging process; however,
HRV was significantly higher in physically
active women at any age.



































Figure 5. Mean heart rate, in
bpm over a period of 6 min for
the young group (N = 10) and
the postmenopausal group (N =
10) under resting conditions in
the supine and sitting positions.
observed in sedentary postmenopausal
women was significant, reflecting the influ-
ence of age, possibly associated with physi-
cal inactivity and deficient hormonal pro-
duction. The design of our study did not
allow us to quantify the participation of each
of these mechanisms in the HRV changes
observed in menopause women.
Based on epidemiological data indicat-
ing a significant increase in the incidence of
cardiovascular disease in postmenopausal
women, several studies have been conducted
in order to determine the effects of hypo-
estrogenism on cardiovascular physiology,
as well as the probable benefits of hormonal
replacement for the prevention of these dis-
eases.
Many observational studies have found
lower rates of coronary heart disease in
women who take postmenopausal estrogen
than in women not receiving this therapy
(15,23). However, the results of a random-
ized, blind, placebo-controlled trial (HERS
study) did not demonstrate any benefit of
hormonal replacement in terms of the sec-
ondary prevention of cardiovascular events.
During an average follow-up of 4.1 years,
treatment with oral conjugated equine estro-
gen plus medroxyprogesterone acetate did
not reduce the overall rate of coronary heart
disease events in postmenopausal women
with established coronary disease (16).
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So far, little is known about the modula-
tion of HRV by hormone replacement therapy
in postmenopausal women. HRV has been
shown to be increased by 17ß-estradiol in an
uncontrolled clinical study (24), a finding
that could at least partly explain the potential
cardioprotective estrogen actions (25).
A study by Christ et al. (25) demon-
strated that hormone replacement therapy
containing progestins may attenuate HRV in
healthy postmenopausal women. Thus, the
addition of progestins to hormone replace-
ment therapy may outweigh the postulated
beneficial effects of estrogens on cardiovas-
cular risk. These observations may explain
at least in part the disappointing results of
the HERS study (25).
The decrease in HRV is related to a re-
duction in parasympathetic activity with ad-
vancing age (21,22). Although the mechan-
ism underlying this finding has not been
clearly defined, there is experimental evi-
dence of a protective effect of vagal stimula-
tion against electrical ventricular vulnerabil-
ity, in addition to other more complex
mechanisms that might explain the relation-
ship between HRV and mortality due to
cardiac events (10). Thus, compared with
young subjects of similar activity status, post-
menopausal women may be at an additional
risk (i.e., beyond that due to aging itself)
(14).
Considering of all these reports, time
domain HRV estimated by ECG monitoring
may offer important information on the au-
tonomic control of the heart in addition to
that obtained by a traditional evaluation of
risk factors. Thus, HRV can be considered a
relatively simple, noninvasive and sensitive
method for studying autonomic modulation
of sinus node compared to others that meas-
ure only average HR values under basal
conditions and in the presence of a physi-
ological stimulus.
Our data indicate a decrease in HRV that
seems to be an expression of a reduction in
autonomic modulation in postmenopausal
women compared to young women, which
most likely was due to the decrease in para-
sympathetic modulation in sinus node. This
decrease can be the result of an age effect,
possibly associated with hormonal factors.
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